BA
SGMO

BlackRock Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

BlackRock Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$652K Sell
213,766
-1,306
-0.6% -$4.76K ﹤0.01% 2063
2016
Q3 		$996K Buy
215,072
+1,001
+0.5% +$5.09K ﹤0.01% 1825
2016
Q2 		$1.24M Sell
214,071
-901
-0.4% -$5.74K ﹤0.01% 1675
2016
Q1 		$1.3M Buy
214,972
+2,806
+1% +$16.8K ﹤0.01% 1620
2015
Q4 		$1.94M Sell
212,166
-57,774
-21% -$445K ﹤0.01% 1423
2015
Q3 		$1.52M Buy
269,940
+94,511
+54% +$779K ﹤0.01% 1459
2015
Q2 		$1.95M Sell
175,429
-11,743
-6% -$151K ﹤0.01% 1287
2015
Q1 		$2.94M Sell
187,172
-51,054
-21% -$790K ﹤0.01% 1097
2014
Q4 		$3.62M Sell
238,226
-47,151
-17% -$573K ﹤0.01% 1051
2014
Q3 		$3.08M Buy
285,377
+216,601
+315% +$2.83M ﹤0.01% 1072
2014
Q2 		$1.05M Sell
68,776
-8,474
-11% -$122K ﹤0.01% 1462
2014
Q1 		$1.4M Sell
77,250
-16,696
-18% -$322K ﹤0.01% 1334
2013
Q4 		$1.3M Buy
93,946
+29,576
+46% +$341K ﹤0.01% 1350
2013
Q3 		$675K Buy
64,370
+31,717
+97% +$315K ﹤0.01% 1701
2013
Q2 		$255K Buy
+32,653
New +$285K ﹤0.01% 2324

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FC
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

BlackRock Advisors's SGMO Position: Q4 2016 in Review

BlackRock Advisors reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 0.61% in Q4 2016, selling an estimated $4.76K and leaving 213,766 shares worth $652K. The position accounts for ﹤0.01% of the portfolio, ranked #2063.

BlackRock Advisors first reported a position in SGMO in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.62M in Q4 2014. 126 funds tracked by Wall St. Rank hold SGMO as of Q4 2016.

  • BlackRock Advisors held 213,766 shares of SANGAMO THERAPEUTICS INC worth $652K as of Q4 2016.
  • BlackRock Advisors sold 1,306 SANGAMO THERAPEUTICS INC shares in Q4 2016, an estimated $4.76K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2063 holding.
  • BlackRock Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's SANGAMO THERAPEUTICS INC position peaked at $3.62M in Q4 2014.
  • 126 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.